Financial Management Professionals’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.6K Buy
425
+8
+2% +$1.5K 0.01% 242
2026
Q1
$82.2K Sell
417
-14
-3% -$2.7K 0.01% 216
2025
Q4
$79.2K Buy
431
+12
+3% +$2.1K 0.01% 217
2025
Q3
$64.2K Buy
419
+24
+6% +$3.63K 0.01% 237
2025
Q2
$55.2K Buy
395
+4
+1% +$561 0.01% 243
2025
Q1
$57.4K Buy
391
+100
+34% +$14.5K 0.01% 242
2024
Q4
$38.1K Sell
291
-47
-14% -$6.58K ﹤0.01% 307
2024
Q3
$53K Buy
338
+43
+15% +$6.94K 0.01% 264
2024
Q2
$46K Buy
295
+13
+5% +$1.96K 0.01% 267
2024
Q1
$38K Buy
282
+16
+6% +$2.12K 0.01% 323
2023
Q4
$36K Buy
266
+12
+5% +$1.56K 0.01% 300
2023
Q3
$34K Sell
254
-4
-2% -$546 0.01% 287
2023
Q2
$37K Sell
258
-310
-55% -$45.6K 0.01% 294
2023
Q1
$79K Buy
568
+334
+143% +$44.9K 0.02% 228
2022
Q4
$32K Buy
234
+95
+68% +$11.9K 0.01% 280
2022
Q3
$15K Sell
139
-118
-46% -$15K ﹤0.01% 400
2022
Q2
$34K Buy
257
+46
+22% +$6.04K 0.01% 272
2022
Q1
$28K Buy
211
+73
+53% +$8.75K 0.01% 291
2021
Q4
$16K Sell
138
-17
-11% -$2K ﹤0.01% 374
2021
Q3
$19K Buy
155
+41
+36% +$4.77K ﹤0.01% 335
2021
Q2
$14K Buy
114
+13
+13% +$1.43K ﹤0.01% 327
2021
Q1
$10K Buy
101
+25
+33% +$2.51K ﹤0.01% 367
2020
Q4
$8K Hold
76
﹤0.01% 390
2020
Q3
$8K Hold
76
﹤0.01% 336
2020
Q2
$8K Buy
+76
New +$7.85K ﹤0.01% 329

Other funds holding AZN

Financial Management Professionals's AZN Position: Q2 2026 in Review

Financial Management Professionals increased its AstraZeneca (AZN) stake by 1.9% in Q2 2026, buying an estimated $1.5K and bringing the position to 425 shares worth $80.6K. The position accounts for 0.01% of the portfolio, ranked #242.

Financial Management Professionals first reported a position in AZN in Q2 2020 and has held it in 25 quarters since. The position peaked at $82.2K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Financial Management Professionals held 425 shares of AstraZeneca worth $80.6K as of Q2 2026.
  • Financial Management Professionals bought 8 AstraZeneca shares in Q2 2026, an estimated $1.5K.
  • AstraZeneca made up 0.01% of Financial Management Professionals's portfolio in Q2 2026, its #242 holding.
  • Financial Management Professionals first reported a position in AstraZeneca in Q2 2020 and has held it in 25 quarters since.
  • Financial Management Professionals's AstraZeneca position peaked at $82.2K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.